|
|
.
See Category: Neoplasms
See Header: Benign carcinoid tumors of other sites
ICD-10 (CM) Code and Descriptor
|
D3A.090 |
Benign carcinoid tumor of the bronchus and lung
|
D3A090 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 55.31%
|
19.12%
|
9.34%
|
5.11%
|
3.34%
|
2.32%
|
1.28%
|
0.85%
|
0.68%
|
0.59%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D3A.090*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,329
|
1,333
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
806
|
808
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
780
|
780
|
|
80053
|
COMPREHEN METABOLIC PANEL |
777
|
777
|
|
71250
|
CT THORAX DX C- |
661
|
661
|
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
581
|
622
|
|
J2353
|
OCTREOTIDE INJECTION, DEPOT |
481
|
12,310
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
427
|
37,450
|
|
71260
|
CT THORAX DX C+ |
423
|
423
|
|
86316
|
IMMUNOASSAY TUMOR OTHER |
368
|
369
|
|
G1004
|
CDSM NDSC |
362
|
464
|
|
82565
|
ASSAY OF CREATININE |
242
|
242
|
|
88341
|
IMHCHEM/IMCYTCHM EA ADD ANTB |
239
|
842
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
234
|
404
|
|
J3010
|
FENTANYL CITRATE INJECTION |
211
|
322
|
|
82948
|
REAGENT STRIP/BLOOD GLUCOSE |
200
|
781
|
|
71045
|
X-RAY EXAM CHEST 1 VIEW |
199
|
227
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
193
|
229
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
167
|
8,368
|
|
71046
|
X-RAY EXAM CHEST 2 VIEWS |
165
|
174
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D3A.090 related to the following DRG Codes:
180-182
|
